Pacritinib Effectiveness in Real-world Settings
Key claim: A site-based retrospective chart review will assess real-world treatment patterns, hematologic and clinical outcomes, and survival with pacritinib in patients with myelofibrosis.
Abstract
This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of medical records of patients with MF.
Why this matters
A site-based retrospective chart review will assess real-world treatment patterns, hematologic and clinical outcomes, and survival with pacritinib in patients with myelofibrosis.